LEGEND BIOTECH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.3 USD | +1.98% |
|
-1.93% | -24.71% |
| Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
| Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 56.36 | 56.36 | 58.11 |
| Spread/Res. | -19.62% | -19.62% | -22.04% |
| Spread/Supp. | +1.98% | +1.98% | +1.77% |
| Support | 44.42 | 44.42 | 44.51 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation
